Participate in a study on pyoderma gangrenosum
Pyoderma gangrenosum (PG) is a rare, ulcerating skin disease that is often secondary to inflammatory conditions such as Crohn’s disease and rheumatoid arthritis.
There has never been a trial of the most commonly used treatments for PG and so little is known about the best treatments to use. The UK Dermatology Clinical Trials Network is now recruiting patients with PG in around 50 hospitals across the UK. Prednisolone & ciclosporin are being compared head-to-head in a randomised controlled trial, with a parallel observational study of topical treatments for patients with less aggressive disease. The trial is being funded by the National Institute for Health Research (NIHR), and is a UK Clinical Research Network portfolio study.
Given that PG is such a rare disease, we need your help to make this trial a success.
To find out further details click here